ADTX Logo

Aditxt, Inc. (ADTX) 

NASDAQ
Market Cap
$2.65M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
366 of 960
Rank in Industry
220 of 550

Largest Insider Buys in Sector

ADTX Stock Price History Chart

ADTX Stock Performance

About Aditxt, Inc.

Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ …

Insider Activity of Aditxt, Inc.

Over the last 12 months, insiders at Aditxt, Inc. have bought $23,454 and sold $29,875 worth of Aditxt, Inc. stock.

On average, over the past 5 years, insiders at Aditxt, Inc. have bought $37,727 and sold $360,508 worth of stock each year.

Highest buying activity among insiders over the last 12 months: HRT FINANCIAL LP (10 percent owner) — $23,454.

The last purchase of 15,636 shares for transaction amount of $23,454 was made by HRT FINANCIAL LP (10 percent owner) on 2024‑10‑15.

List of Insider Buy and Sell Transactions, Aditxt, Inc.

2024-10-16Sale10 percent owner
25,534
2.5257%
$1.17$29,875-67.91%
2024-10-15Purchase10 percent owner
15,636
1.9829%
$1.50$23,454-68.15%
2023-09-07Sale
20,800
12.7911%
$33.23$691,140-88.24%
2022-07-19PurchaseChief Executive Officer
1
$20,000.00$20,000-84.78%
2021-06-01PurchaseCHIEF INNOVATION OFFICER
490
0.0034%
$2.93$1,436-64.24%
2021-06-01PurchaseCHIEF OPERATING OFFICER
3,400
0.0238%
$2.93$9,974-64.24%
2021-06-01PurchaseCHIEF EXECUTIVE OFFICER
3,400
0.0238%
$2.93$9,974-64.24%
2021-06-01Purchasedirector
10,000
0.07%
$2.93$29,344-64.24%
2021-05-27PurchaseCHIEF INNOVATION OFFICER
185
0.0013%
$2.70$500-59.62%
2021-05-26PurchasePRINCIPAL ACCOUNTING OFFICER
2,500
0.0172%
$2.68$6,700-59.70%
2021-05-25PurchaseCHIEF INNOVATION OFFICER
417
0.0026%
$2.39$998-58.65%
2021-05-25PurchaseCHIEF FINANCIAL OFFICER
4,220
0.0279%
$2.56$10,803-58.65%

Insider Historical Profitability

<0.0001%
HRT FINANCIAL LP10 percent owner
0
0%
$0.1911
Shabahang ShahrokhCHIEF INNOVATION OFFICER
1016098
7.1384%
$0.1930
Albanna RowenaCHIEF OPERATING OFFICER
751620
5.2804%
$0.1910
Pankovcin CorinneCHIEF FINANCIAL OFFICER
114220
0.8024%
$0.1910
Runge Jeffrey W.director
12500
0.0878%
$0.1910

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.